Novartis said that its generic drug unit, Geneva Pharmaceuticals, had launched a copycat version of GlaxoSmithKline's top-selling Augmentin antibiotic in the United States. The company has started distributing the drug to its customers, according to a Geneva spokeswoman.
展开▼